Angiotensin-(1-7) and Energy Expenditure in Human Obesity

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 26, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Obesity

Interventions

DRUG

Angiotensin-(1-7)

This is a biologically active beneficial hormone of the renin-angiotensin system.

DRUG

Saline

Saline will be used as the placebo comparator.

Trial Locations (1)

Penn State Milton S. Hershey Medical Center, Hershey

All Listed Sponsors

lead

Amy Arnold

OTHER